Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher M Counter

Showing results (41-50 of 89) with videos related to

Pageof 9
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 2, 2018
Copper Chelation as Targeted Therapy in a Mouse Model of Oncogenic BRAF-Driven Papillary Thyroid CancerMengMeng Xu, Michael Casio, Danielle E Range, et al.
Plos One|December 3, 2016
Isoform-Specific Effects of Wild-Type Ras Genes on Carcinogen-Induced Lung Tumorigenesis in MiceJamie D Weyandt, John M Carney, Elizabeth N Pavlisko, et al.
The Journal of Clinical Investigation|July 31, 2018
Wnt signaling suppresses MAPK-driven proliferation of intestinal stem cellsZahra Kabiri, Gediminas Greicius, Hamed Zaribafzadeh, et al.
Cancer Research|June 3, 2005
Genetic modeling of human rhabdomyosarcomaCorinne M Linardic, Diane L Downie, Stephen Qualman, et al.
NPJ Precision Oncology|April 3, 2026
Profiling KRAS mutations in whole blood by error-corrected maximum depth sequencingRyne C Ramaker, Yuchen Zhang, John H Strickler, et al.
Nature Communications|September 10, 2021
Oncogenic KRAS is dependent upon an EFR3A-PI4KA signaling axis for potent tumorigenic activityHema Adhikari, Walaa E Kattan, Shivesh Kumar, et al.
The Journal of Biological Chemistry|May 11, 2010
cPLA2 regulates the expression of type I interferons and intracellular immunity to Chlamydia trachomatisMark J Vignola, David F Kashatus, Gregory A Taylor, et al.
Cancer Research|July 20, 2007
The PAX3-FKHR fusion gene of rhabdomyosarcoma cooperates with loss of p16INK4A to promote bypass of cellular senescenceCorinne M Linardic, Sarasija Naini, James E Herndon, et al.
Plos One|October 10, 2015
Wild-Type Hras Suppresses the Earliest Stages of Tumorigenesis in a Genetically Engineered Mouse Model of Pancreatic CancerJamie D Weyandt, Benjamin L Lampson, Sherry Tang, et al.
The Journal of Biological Chemistry|January 8, 2008
Tethering telomeric double- and single-stranded DNA-binding proteins inhibits telomere elongationKatherine T Etheridge, Sarah A Compton, Katharine S Barrientos, et al.
Pageof 9

Showing results (41-50 of 89) with videos related to

Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 2, 2018
Copper Chelation as Targeted Therapy in a Mouse Model of Oncogenic BRAF-Driven Papillary Thyroid CancerMengMeng Xu, Michael Casio, Danielle E Range, et al.
Plos One|December 3, 2016
Isoform-Specific Effects of Wild-Type Ras Genes on Carcinogen-Induced Lung Tumorigenesis in MiceJamie D Weyandt, John M Carney, Elizabeth N Pavlisko, et al.
The Journal of Clinical Investigation|July 31, 2018
Wnt signaling suppresses MAPK-driven proliferation of intestinal stem cellsZahra Kabiri, Gediminas Greicius, Hamed Zaribafzadeh, et al.
Cancer Research|June 3, 2005
Genetic modeling of human rhabdomyosarcomaCorinne M Linardic, Diane L Downie, Stephen Qualman, et al.
NPJ Precision Oncology|April 3, 2026
Profiling KRAS mutations in whole blood by error-corrected maximum depth sequencingRyne C Ramaker, Yuchen Zhang, John H Strickler, et al.
Nature Communications|September 10, 2021
Oncogenic KRAS is dependent upon an EFR3A-PI4KA signaling axis for potent tumorigenic activityHema Adhikari, Walaa E Kattan, Shivesh Kumar, et al.
The Journal of Biological Chemistry|May 11, 2010
cPLA2 regulates the expression of type I interferons and intracellular immunity to Chlamydia trachomatisMark J Vignola, David F Kashatus, Gregory A Taylor, et al.
Cancer Research|July 20, 2007
The PAX3-FKHR fusion gene of rhabdomyosarcoma cooperates with loss of p16INK4A to promote bypass of cellular senescenceCorinne M Linardic, Sarasija Naini, James E Herndon, et al.
Plos One|October 10, 2015
Wild-Type Hras Suppresses the Earliest Stages of Tumorigenesis in a Genetically Engineered Mouse Model of Pancreatic CancerJamie D Weyandt, Benjamin L Lampson, Sherry Tang, et al.
The Journal of Biological Chemistry|January 8, 2008
Tethering telomeric double- and single-stranded DNA-binding proteins inhibits telomere elongationKatherine T Etheridge, Sarah A Compton, Katharine S Barrientos, et al.
Pageof 9